Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mario L. Meyer"'
Autor:
Uzair B. Chaudhary, Carol A. Sherman, Elizabeth Garrett-Mayer, Mario L. Meyer, Andrew S. Kraft, Matthew Beldner, Alberto J. Montero, Mark R. Green
Publikováno v:
BMC Cancer, Vol 7, Iss 1, p 231 (2007)
BMC Cancer
BMC Cancer
Background A platinum doublet is the current standard treatment for good performance status patients with advanced non-small cell lung cancer (NSCLC) and extensive stage small cell lung cancer (SCLC) with good performance status. However, platinum-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7548af44905cfbed54da22b5da78111e
https://doi.org/10.1186/1471-2407-7-231
https://doi.org/10.1186/1471-2407-7-231
Autor:
Carol A. Sherman, Mario L. Meyer, Steven Dunder, Andrew S. Kraft, Alberto J. Montero, Uzair B. Chaudhary, Mark R. Green, John Hayslip, Shanta Salzer
Publikováno v:
BMC Cancer, Vol 7, Iss 1, p 221 (2007)
BMC Cancer
BMC Cancer
Background COX-2 inhibitors, such as celecoxib, and ubiquitin-proteasome pathway inhibitors, such as bortezomib, can down-regulate NF-κB, a transcription factor implicated in tumor growth. The objective of this study was to determine the maximum tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0931f544dbff12bee5d3b291ab18d93
http://www.biomedcentral.com/1471-2407/7/221
http://www.biomedcentral.com/1471-2407/7/221
Publikováno v:
Clinical lung cancer. 5
Malignant pleural mesothelioma is an aggressive but rare malignancy with a dismal prognosis. It is traditionally resistant to chemotherapy. Antifolate agents have recently shown promising data in the treatment of this malignancy. Pemetrexed is a mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e9ffec5ded5ae3d55d228237bc14684
https://pubmed.ncbi.nlm.nih.gov/15117426
https://pubmed.ncbi.nlm.nih.gov/15117426
Autor:
Uzair B. Chaudhary, Shanta Salzer, Alberto J. Montero, S. Dunder, Mark R. Green, Mario L. Meyer, Andrew S. Kraft, F. Brescia
Publikováno v:
Journal of Clinical Oncology. 24:13051-13051
13051 Background: The ubiquitin-proteosome pathway plays an important role in cell cycle regulation, neoplastic growth, and metastasis. Nuclear factor-kB (NF-kB) is a key transcription factor in cancer, primarily regulated by proteosome-mediated degr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::786ded95a40b28ee4e67ebbf08220e07
https://doi.org/10.1200/jco.2006.24.18_suppl.13051
https://doi.org/10.1200/jco.2006.24.18_suppl.13051